Back to top
more

CryoCell International (CCEL)

(Delayed Data from AMEX)

$8.73 USD

8.73
53,149

+0.40 (4.82%)

Updated Nov 8, 2024 03:58 PM ET

After-Market: $9.05 +0.32 (3.62%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 45% (138 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Cash flow Statements

Fiscal Year End for CryoCell International Inc falls in the month of November.

All data in Millions except Per Share data.

Cash Flow From Operations, Investments & Financial Activities

11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019
Cash Flow From Operations, Investments & Financial
Activities		          
Net Income (Loss) -9.52 2.77 2.08 3.62 2.29
Depreciation/Amortization & Depletion 1.73 1.83 1.38 0.72 0.51
Net Change from Assets/Liabilities 5.99 4.25 4.86 3.76 2.28
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 10.72 -0.27 -0.40 0.37 1.24
Net Cash From Operating Activities 8.92 8.57 7.93 8.47 6.32
Property & Equipment -6.84 -10.30 -1.83 -0.10 -0.66
Acquisition/ Disposition of Subsidiaries 0.00 0.00 0.00 0.00 0.00
Investments -0.51 0.02 0.00 0.81 -0.03
Other Investing Activities -0.80 -5.00 -5.12 -0.35 0.00
Net Cash from Investing Activities -8.14 -15.28 -6.95 0.36 -0.69

Uses of Funds

11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019
Issuance (Repurchase) of Capital Stock -0.80 -1.27 1.03 0.04 -0.99
Issuance (Repayment) of Debt -0.16 7.01 -4.10 -3.10 -4.10
Increase (Decrease) Short-Term Debt -1.05 2.27 0.00 0.00 0.00
Payment of Dividends & Other Distributions 0.00 -7.67 0.00 0.00 0.00
Other Financing Activities -0.07 -0.20 0.00 -1.95 -0.05
Net Cash from Financing Activities -2.07 0.15 -3.07 -5.00 -5.13
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00 0.00
Net Change In Cash & Equivalents -1.30 -6.56 -2.10 3.82 0.50
Cash at Beginning of Period 1.70 8.26 10.36 6.54 6.04
Cash at End of Period 0.41 1.70 8.26 10.36 6.54
Diluted Net EPS -1.14 0.33 0.25 0.45 0.27

Fiscal Year End for CryoCell International Inc falls in the month of November.

All data in Millions except Per Share data.

Cash Flow From Operations, Investments & Financial Activities

8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023
Cash Flow From Operations, Investments & Financial
Activities		          
Net Income (Loss) 2.26 1.21 0.56 -9.52 1.67
Depreciation/Amortization & Depletion 0.70 0.36 0.17 1.73 1.32
Net Change from Assets/Liabilities 0.19 -0.86 -1.44 5.99 1.46
Net Cash from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Other Operating Activities 0.70 0.71 0.36 10.72 1.13
Net Cash From Operating Activities 3.85 1.42 -0.36 8.92 5.58
Property & Equipment -2.40 -2.21 -0.46 -6.84 -5.12
Acquisition/ Disposition of Subsidiaries 0.00 0.00 0.00 0.00 0.00
Investments -0.30 0.05 0.12 -0.51 -0.51
Other Investing Activities -1.07 -0.93 0.00 -0.80 -0.53
Net Cash from Investing Activities -3.76 -3.10 -0.34 -8.14 -6.16

Uses of Funds

8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023
Issuance (Repurchase) of Capital Stock -1.42 -1.41 -0.17 -0.80 -0.80
Issuance (Repayment) of Debt -0.11 -0.08 -0.04 -0.16 -0.12
Increase (Decrease) Short-Term Debt 1.00 3.00 0.75 -1.05 0.45
Payment of Dividends & Other Distributions 0.00 0.00 0.00 0.00 0.00
Other Financing Activities 0.23 0.23 0.00 -0.07 -0.07
Net Cash from Financing Activities -0.30 1.74 0.54 -2.07 -0.53
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00 0.00
Net Change In Cash & Equivalents -0.21 0.06 -0.16 -1.30 -1.12
Cash at Beginning of Period 0.41 0.41 0.41 1.70 1.70
Cash at End of Period 0.20 0.47 0.25 0.41 0.58
Diluted Net EPS 0.13 0.08 0.07 -1.34 0.08